Quizartinib (AC220): a promising option for acute myeloid leukemia

Zhou, F; Ge, Z; Chen, BA

Chen, BA (reprint author), Southeast Univ, Zhongda Hosp, Key Dept Jiangsu Med, Dept Hematol & Oncol,Med Sch, Dingjiaqiao 87, Nanjing 210009, Jiangsu, Peoples R China.

DRUG DESIGN DEVELOPMENT AND THERAPY, 2019; 13 (): 1117

Abstract

Quizartinib is an effective therapy for patients with FLT3-ITD acute myeloid leukemia (AML) by continuing to inhibit the activity of FLT3 gene, leadin......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索